Recent Finacing
Recent Raise
Armetheon is a clinical-stage biopharma developing tecarfarin, a VKA oral anticoagulant, in a 3,000‑patient FDA‑SPA pivotal TACT trial comparing to warfarin across anticoagulation indications, including mechanical valves.
